IL6

interleukin 6

Associated Studies

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis

2025 | Rostami-Afshari et al.

Phenotype: ME/CFS, ME/CFS - Canadian Consensus Criteria (CCC) 2003, Post-exertional malaise (PEM)
Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS

2025 | Shahbaz et al.

Phenotype: Long COVID, ME/CFS, ME/CFS - Canadian Consensus Criteria (CCC) 2003, Post-exertional malaise (PEM)
Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS

2025 | Che et al.

Phenotype: ME/CFS
Blood parameters differentiate post COVID-19 condition from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia

2025 | Giménez-Orenga et al.

Phenotype: ME/CFS
Gene Expression Factor Analysis to Differentiate Pathways Linked to Fibromyalgia, Chronic Fatigue Syndrome, and Depression in a Diverse Patient Sample

2015 | Iacob et al.

Phenotype: ME/CFS, ME/CFS - Fukuda 1994 (CDC) Criteria
Abnormalities of AMPK Activation and Glucose Uptake in Cultured Skeletal Muscle Cells from Individuals with Chronic Fatigue Syndrome

2015 | Brown et al.

Phenotype: ME/CFS, ME/CFS - Fukuda 1994 (CDC) Criteria

Details

HGNC: HGNC:6018
GeneCards: IL6
NCBI: 3569
Ensembl: ENSG00000136244
UniProt: P05231
OMIM: 147620
UCSC: uc064bxs.1
VEGA: OTTHUMG00000023178
ENA: M18403
Alias Symbols: IL-6, BSF2, HGF, HSF
Previous Symbols: IFNB2
Alias Names: "interferon, beta 2"
Previous Names: "interleukin 6 (interferon, beta 2)"